Evidence map›Paper›PMID 38895984›Full record

ArticleProtein science : a publication of the Protein Society2024

Evolution of fungal tuberculosis necrotizing toxin (TNT) domain-containing enzymes reveals divergent adaptations to enhance NAD cleavage.

Eugenio Ferrario, Juha Pekka Kallio, Mahdi Emdadi, Øyvind Strømland, Johannes G M Rack, Mathias Ziegler

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eugenio FerrarioDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-6429-7980
Juha Pekka KallioDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0003-3092-4012
Mahdi EmdadiDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0009-0007-6612-6019
Øyvind StrømlandDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0003-2841-4638
Johannes G M RackMRC Centre for Medical Mycology, University of Exeter, Exeter, UK.ORCID 0000-0001-8341-6439
Mathias ZieglerDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-6961-2396

Funding

H2020 Marie Skłodowska-Curie Actions, Grant Agreement PoLiMeR,No.812616Medical Research Council (MRC) MR/X007472/1Norwegian Research Council 302314
6 · The paper itself

Abstract

Tuberculosis necrotizing toxin (TNT) is a protein domain discovered on the outer membrane of Mycobacterium tuberculosis (Mtb), and the fungal pathogen Aspergillus fumigatus. TNT domains have pure NAD(P) hydrolytic activity, setting them apart from other NAD-cleaving domains such as ADP-ribosyl cyclase and Toll/interleukin-1 receptor homology (TIR) domains which form a wider set of products. Importantly, the Mtb TNT domain has been shown to be involved in immune evasion via depletion of the intracellular NAD pool of macrophages. Therefore, an intriguing hypothesis is that TNT domains act as "NAD killers" in host cells facilitating pathogenesis. Here, we explore the phylogenetic distribution of TNT domains and detect their presence solely in bacteria and fungi. Within fungi, we discerned six TNT clades. In addition, X-ray crystallography and AlphaFold2 modeling unveiled clade-specific strategies to promote homodimer stabilization of the fungal enzymes, namely, Ca

Indexed as

Mycobacterium tuberculosisNADAspergillus fumigatusCrystallography, X-RayEvolution, MolecularFungal ProteinsModels, MolecularNAD+ NucleosidasePhylogenyProtein DomainsFungal ProteinsNADNAD+ NucleosidaseactinomycetesAscomycotaextracellular NADFusarium oxysporumhomodimer stabilizationhost defenseNADaseNeurospora crassaplant immunity

Identifiers

PMID38895984
PMCPMC11187862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.